MC2 Therapeutics is a pharmaceutical company applying its proprietary PAD™ technology – a new class of cream and eye droplet – to develop a pipeline of new topical drugs and medical devices that addresses the major problem of non-compliance of otherwise highly efficacious and safe topical therapies (dermatology and ophthalmology).